53 results on '"Calo', Lorenzo"'
Search Results
2. Could nutritional therapy take us further in our approaches to Fabry disease?
3. Oxidative stress – chronic kidney disease – cardiovascular disease: A vicious circle
4. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
5. Increased rho kinase activity in mononuclear cells of dialysis and stage 3–4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications
6. Bartter/Gitelman syndromes as a model to study systemic oxidative stress in humans
7. Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients
8. Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients
9. Bartter’s and Gitelman’s diseases
10. Salivary Glands: A New Player in Phosphorus Metabolism
11. Salivary Phosphorus and Phosphate Content of Beverages: Implications for the Treatment of Uremic Hyperphosphatemia
12. Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells
13. Salivary Phosphate Secretion in Chronic Kidney Disease
14. Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
15. Ultrasound for the Clinical Management of Vascular Access Cannulation and Needle Position in Hemodialysis Patients
16. Walnuts Reduce Aortic ET-1 mRNA Levels in Hamsters Fed a High-Fat, Atherogenic Diet
17. Aldosterone and Refractory Hypertension: A Prospective Cohort Study
18. Antioxidant effect of l-carnitine and its short chain esters : Relevance for the protection from oxidative stress related cardiovascular damage
19. Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients
20. Reduced mRNA and Protein Content of Rho Guanine Nucleotide Exchange Factor (RhoGEF) in Bartter’s and Gitelman’s Syndromes: Relevance for the Pathophysiology of Hypertension
21. Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients
22. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes
23. Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome
24. Analysis of Gq protein alpha subunit mRNA expression in human monocytes: relevance of the purification step
25. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis
26. Bartter and Gitelman syndromes
27. Bartter's and Gitelman's Syndromes
28. Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension
29. To reconsider (limit) the use of phosphate based food and beverages additives. A real need for health preservation
30. Hypomagnesaemia, cardiovascular–renal negative effects and Gitelman's syndrome: A paradox awaiting resolution
31. Effect of olmesartan medoxomil on p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients
32. Autonomic Nervous System Function in Chronic Hypotension Associated With Bartter and Gitelman Syndromes
33. Hemodiafiltration and reduction of inflammation in dialysis patients
34. Phosphate Content of Beverages in Addition to Food Phosphate Additives: Real and Insidious Danger for Renal Patients
35. Salt and aldosterone do not get along with each other: implication of mineralocorticoid receptors in the profibrotic action of aldosterone
36. Association of Serum Phosphorus Concentration With Cardiovascular Risk
37. High phosphate content beverages in dialysis patients: Relevance for hyperphosphatemia and cardiovascular risk
38. Aldosterone-mediated endothelial remodeling and oxidative stress
39. Aldosterone and refractory hypertension
40. RhoA, p115RhoAGEF and RhoAGDI in Bartter’s/Gitelman’s Syndromes (BS/GS). Relevance for angiotensin II (Ang II) signaling
41. Oxidative stress and profibrotic action of aldosterone
42. Antioxidant and antiinflammatory effect of carvedilol in mononuclear cells of hypertensive patients
43. Regulator of G protein signaling–2 and control of vascular tone in bartter's/gitelman's sydrome
44. RGS2 expression and intracellular ca 2+ mobilization in fibroblasts from hypertensive patients
45. Myocardial function in Bartter's and Gitelman's syndromes
46. Oxidative stress related proteins in a Conn’s adenoma tissue
47. Rho kinase and PAI-1 in Bartter’s and Gitelman’s syndromes. relevance for angiotensin II signaling
48. Lack of C 242T polymorphism of p22 phox in Bartter’s and Gitelman’s syndromes. Implications for redox state and vascular tone regulation
49. Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity
50. Redox signaling and vascular reactivity in Bartter's and Gitelman's syndromes (BS/GS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.